# An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults

> **NCT00615836** · PHASE3 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 554 (actual)

## Conditions studied

- Nocturia

## Interventions

- **DRUG:** Desmopressin Melt

## Key facts

- **NCT ID:** NCT00615836
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 554 (ACTUAL)
- **Last updated:** 2015-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00615836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00615836, "An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00615836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*